Navigation Links
Thoratec Schedules Second Quarter Conference Call, Webcast
Date:7/24/2012

PLEASANTON, Calif., July 24, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter of fiscal year 2012 on Wednesday, August 1.

The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Wednesday, August 1, hosted by Gary F. Burbach, President and Chief Executive Officer.

The teleconference can be accessed by calling (719) 325-2445, passcode 2804068. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://edge.media-server.com/m/p/9k74r7b7/lan/en, or http://www.thoratec.com.

A replay of the conference call will be available through Wednesday, August 8, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode 2804068.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered trademarks of Thoratec Co
'/>"/>

SOURCE Thoratec Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thoratec Reports First Quarter 2012 Results
2. Thoratec Schedules First Quarter Conference Call, Webcast
3. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
4. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
5. Sinovac Schedules 2012 Annual Meeting of Shareholders
6. Mylan Schedules Second Quarter 2012 Financial Results Conference Call and Live Webcast
7. China Botanic Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results
8. Ampio Pharmaceuticals Schedules 2012 Update Webcast
9. Heartware Schedules First Quarter Conference Call And Webcast
10. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
11. Insmed to Host 2012 Second Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  Advanced Medical Isotope Corporation ... primarily in the development of brachytherapy devices and ... announced that it has filed a de ... Administration ("FDA") for marketing clearance for its patented ... the U.S. Food, Drug and Cosmetic Act (the ...
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
(Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... Terumo Heart Inc., a wholly owned subsidiary of Terumo ... worldwide expansion of its DuraHeart(TM) Left-Ventricular Assist System (LVAS) ... MD and Michiel Morshuis, MD, cardiothoracic surgeons at the ... Center NRW, University Hospital of the Ruhr-University of Bochum ...
... Non-drug Procedure for Asthma Highlighted at ATS 2009SUNNYVALE, ... Intervention Research 2 (AIR2) Trial of the Alair(R) ... announced today at ATS 2009, the International Conference ... Calif . The AIR2 results demonstrated statistically ...
Cached Medicine Technology:Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 2Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 3Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System 4Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 2Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 3Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma 4
(Date:12/25/2014)... 2014 Plugin creators from Pixel Film ... fully customizable business presentation tool made specifically for ... 5k business tool, users can now display their stats ... Pixel Film Studios. “ProFire 5k gives users a multiple ... professionalism to a presentation” , Pixel Film Studios takes ...
(Date:12/24/2014)... Over 700 toys, that’s what AlignLife ... is 700 smiling little faces this holiday that might ... in monetary donations was given to the various charities ... they incur through the year. Some of the charities ... Haven , Shrine's Children's Hospitals, Toys for Tots and ...
(Date:12/24/2014)... CA (PRWEB) December 24, 2014 New studies ... susceptible to hearing loss related depression (March 6, 2014, JAMA ... with gradual hearing loss (about 50 percent according to recent ... positive effect on how a person feels and relates to ... that overall improvements are also made by way of:, ...
(Date:12/24/2014)... December 25, 2014 The report “Stivarga ... focuses on the current treatment landscape, unmet needs, current ... Stivarga is a drug which is used in the ... orally administered and is also prescribed to patients who ... is FDA approved is a multi-kinase inhibitor and it ...
(Date:12/24/2014)... News) -- Hepatitis C infection does not contribute to mental ... Treatment advances have made it possible for people with ... thinking problems, mood swings and other types of mental impairment ... that long-term infections with other viruses -- a common problem ... of the prime suspects has been the hepatitis C virus, ...
Breaking Medicine News(10 mins):Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2
... it, study shows , MONDAY, July 27 (HealthDay News) ... guard against future heart trouble once a cardiovascular event ... of these patients are referred for the therapy, a ... hospitalized patients with a qualifying cardiovascular disease event should ...
... , , SWIFTWATER, Pa., ... (EURONEXT: SAN and NYSE: SNY ), announced today that ... Fluzone((R)), Influenza Virus Vaccine. Fluzone vaccine is indicated for active immunization ... caused by influenza virus subtypes A and type B contained in ...
... , , ... residents have saved over $7.3 million on prescription medications through Tennessee ... program. Tennessee Drug Card, which offers free discount drug cards ... restrictions to membership, no income requirements, no age limitations, and there ...
... , MINNEAPOLIS, July 27 Cars for ... their worthy vessels to the first annual Cars for Courage Boat Drive. ... and CBS Radio. , , This unique event is set ... Event Center parking lot, 687 Excelsior Blvd., Excelsior, Minn. , , ...
... watchful waiting , MONDAY, July 27 (HealthDay News) -- ... prostate cancer surgery but leaves unanswered the complicated question of ... just watchful waiting. , The study of almost 13,000 American ... a cancerous prostate gland -- between 1987 and 2005 found ...
... (LRF) is pleased to announce that the 2009 Millennium ... has been awarded to Kai Fu, MD, PhD, Associate ... , Lymphoma, the most common type of ... and non-Hodgkin lymphoma (NHL). According to a 2008 ...
Cached Medicine News:Health News:Many Heart Attack Patients Not Referred to Cardiac Rehab 2Health News:Many Heart Attack Patients Not Referred to Cardiac Rehab 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 2Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 3Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 4Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 5Health News:Sanofi Pasteur Begins Shipments of Fluzone(R), Influenza Virus Vaccine for 2009-2010 Seasonal Influenza 6Health News:Tennessee Drug Card Has Saved Residents Over $7.3 Million 2Health News:CBS Radio presents Cars for Courage Boat Drive 2Health News:Men Who Have Prostate Cancer Surgery Do Well 2Health News:Men Who Have Prostate Cancer Surgery Do Well 3Health News:Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research 2
More Info Lacrimal Intubation Set w/Retrieval Device. Size: Probes 23g x 4-1/4"....
... CORNEO-GAGE PLUS pachometers are acknowledged to be ... measurement-reproducible pachometers available. These benefits are due ... transducers and smallest tip footprint available coupled ... average for every displayed reading. Thus corneal ...
... Each bath container of the Robot ... individual covers that are automatically lifted and ... combination with the innovative drip preventing system ... carryover and reagent consumption. An acrylic glass ...
... use of the Leica CM1900 as well ... the instrument of choice in many routine ... open top stainless steel cryochamber with separate ... ample space for convenient working and storage ...
Medicine Products: